| Identification | Back Directory | [Name]
bleomycin A6 | [CAS]
37293-17-7 | [Synonyms]
Boanmycin
bleomycin A6
Pingyangmycin A6
Zhengguangmycin A6
N1-[3-[[4-[(3-Aminopropyl)amino]butyl]amino]propyl]bleomycinamide
Bleomycinamide, N1-[3-[[4-[(3-aminopropyl)amino]butyl]amino]propyl]- | [Molecular Formula]
C60H96N20O21S2 | [MDL Number]
MFCD01751489 | [MOL File]
37293-17-7.mol | [Molecular Weight]
1497.67 |
| Hazard Information | Back Directory | [Uses]
Boanmycin is an antibiotic with antitumor activity that induces cellular senescence and apoptosis[1][2][3]. | [in vivo]
Boanmycin (BAM) (i.p., 10 or 15 mg/kg, twice a week, 5 weeks) can effectively inhibit the growth of tumors in BALB/c nude mice with HT-29, Hce-8693 or CT-26 cells[1].
| Animal Model: | BALB/c nude mice with HT-29 or Hce-8693 cells[1] | | Dosage: | 10 or 15 mg/kg | | Administration: | Intraperitoneal injection; twice a week; 5 weeks | | Result: | Significantly inhibited tumor growth by 89% at 10 mg/kg and by 92% at 15 mg/kg in mice with HT-29 model, also inhibited tumor growth by 90% at 10 mg/kg and by 92% at 15 mg/kg in mice with Hce-8693 model. |
| Animal Model: | BALB/c nude mice with CT-26 cells[1] | | Dosage: | 10 mg/kg | | Administration: | Intramuscular injection; every second day; 10 times | | Result: | Inhibited subcutaneous tumor growth by 88% and cecal tumor by 99%. |
| [References]
[1] Y C Deng, et al. Activity of boanmycin against colorectal cancer. World J Gastroenterol. 2001 Feb;7(1):93-7. DOI:10.3748/wjg.v7.i1.93
[2] Hao Tang, et al. Effect of boanmycin on apoptosis and cell cycle of human esophageal cancer(Eca-109) cells]. Ai Zheng. 2002 Aug;21(8):855-9. PMID:12478892
[3] Peng Chen, et al. The chemotherapeutic drug boanmycin induces cell senescence and senescence-associated secretory phenotype factors, thus acquiring the potential to remodel the tumor microenvironment. Anticancer Drugs. 2016 Feb;27(2):84-8. DOI:10.1097/CAD.0000000000000304 |
|
|